A phase II randomized placebo-controlled study investigating the combination of yiv-906 and sorafenib (SORA) in HBV (+) patients (Pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Harding, J. J.; Abou-Alfa, G. K.; Shi, Y.; Whang-Peng, J.; Yuen, M. F.; Saif, W. M.; Tian, A.; Gu, S.; Lam, W.; Liu, S. H.; Cheng, Y. C.; Chu, E.; Yen, Y. |
| Abstract Title: | A phase II randomized placebo-controlled study investigating the combination of yiv-906 and sorafenib (SORA) in HBV (+) patients (Pts) with advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 2020 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000530922700579 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.4_suppl.TPS601 |
| Notes: | Meeting Abstract: TPS601 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
